BioDiscovery

BioDiscovery, Inc.
Private
Industry Computer software – Genomics Cytogenetics, Human Health
Founded California (1997 (1997))
Founder Soheil Shams
Headquarters El Segundo, California, United States
Area served
 Worldwide
Website BioDiscovery

BioDiscovery is a scientific software company based in El Segundo, California, focused on genetic research and genomic analysis.

Products

BioDiscovery's software product consists of three umbrella offerings: Nexus Copy Number (for microarray and NGS copy number analysis), NxClinical (for CNV analysis and visualization), Nexus Expression (for microarray and NGS gene expression) and ImaGene (machine vision microarray analysis).

In addition, the company hosts Nexus DB (using Amazon's AWS as of October 2011), which is a cloud-based collaborative extension to the Nexus product line.

Scientific references

BioDiscovery's products have been used in research and publication, and have numerous peer-reviewed citations, including:

Cell: Identification of PHLPP1 as a Tumor Suppressor Reveals the Role of Feedback Activation in PTEN-Mutant Prostate Cancer Progression.[1]

Nature: A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1.[2]

European Journal of Human Genetics: Practical guidelines for interpreting copy number gains detected by high-resolution array in routine diagnostics.[3]

Roche.[4]

Application of Nexus Copy Number Software for CNV Detection and Analysis. Darvishi K. Curr Protoc Hum Genet. 2010 April; Chapter 4: Unit4.14.

History

BioDiscovery was founded in 1997 in Los Angeles, California, and has been focused on analyzing data from high-throughput microarrays and next-generation sequencing (NGS). The company's present headquarters are in El Segundo, California.

See also

References

  1. ↑ "Identification of PHLPP1 as a Tumor Suppressor Reveals the Role of Feedback Activation in PTEN-Mutant Prostate Cancer Progression". Cancer Cell. 20: 173–186. 2011-08-16. doi:10.1016/j.ccr.2011.07.013. Retrieved 2012-11-24.
  2. ↑ "A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1". Nature. 477: 349–353. doi:10.1038/nature10368. PMC 3628753. Archived from the original on September 25, 2011. Retrieved October 24, 2011.
  3. ↑
  4. ↑ "High Resolution Copy Number Analysis of Parkinson's Samples Using Nexus Copy Number and Roche NimbleGen Microarrays" (PDF). Nimblegen.com. Retrieved 2012-11-24.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.